Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral anticoagulation versus no anticoagulation in hemodialysis patients with atrial fibrillation
2016-003398-16Phase 4Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of warfarin, fluindione and acenocoumarol in Atrial fibrillation (AFib) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Combined major bleeding and stroke endpoint. Started Nov 2016; status: terminated.
02
Drugs
warfarinfluindioneacenocoumarol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2016-003398-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003398-16.